Keyphrases
COVID-19
100%
Apixaban
83%
Convalescent Plasma
80%
Rivaroxaban
70%
Anti-Xa Level
61%
Hemostasis
56%
Transfusion
55%
Thrombosis
43%
Von Willebrand Factor
40%
Prothrombin Complex Concentrate
40%
Soluble Adenylyl Cyclase
40%
Hospitalized Patients
37%
Anti-Xa
34%
Therapeutic Plasma Exchange
33%
Therapeutic Apheresis
30%
Factor Xa Inhibitors
30%
Receptor-binding Domain
28%
Major Bleeding
28%
Peripheral Venous Access
27%
Proficiency Testing
27%
College of American Pathologists
27%
Apheresis Procedures
27%
Clinical Transfusion Medicine
27%
Selected Topic
27%
Adenylyl Cyclase
27%
Transfusion Medicine
27%
Aptamer
27%
Red Blood Cell Transfusion
27%
Major Bleeding Events
24%
Platelets
24%
Apheresis
23%
Mitochondrial Proteins
23%
Houston
22%
International Society
22%
Convalescent Plasma Therapy
21%
Allogeneic Blood Transfusion
21%
Committee Member
20%
Methodist
20%
Spike Protein
19%
Clinical Outcomes
18%
High Titer
18%
Propensity Score Matching
17%
Direct Oral Anticoagulants
17%
Bleeding
17%
Bicarbonate
16%
Hematological Diseases
16%
Ultrasound-guided
16%
Central Venous Catheter
16%
Dosing Regimen
16%
Parenteral Anticoagulants
16%
Medicine and Dentistry
COVID-19
72%
Apixaban
55%
Blood Transfusion
43%
Rivaroxaban
42%
Von Willebrand Factor
40%
Prothrombin Complex
40%
Blood Stasis
38%
Thrombosis
36%
Major Bleeding
33%
Plasma Exchange
33%
Apheresis
33%
Heart Surgery
31%
Bleeding
30%
Blood Clotting Factor 10a Inhibitor
28%
Pathologist
27%
Transfusion Medicine
27%
Platelet
26%
Severe Acute Respiratory Syndrome Coronavirus 2
24%
Receptor Binding
22%
Diseases
21%
Infection
20%
Acute Kidney Injury
20%
Hemoglobin Determination
20%
Coronavirinae
19%
Anticoagulation
19%
Erythrocyte
19%
Antithrombotic
17%
Oral
17%
Direct Oral Anticoagulant
17%
Venous Thromboembolism
15%
Central Venous Catheter
15%
Erythrocyte Transfusion
15%
Randomized Controlled Trial
15%
Blood Product
15%
Mixing Study
14%
Hypochromic Anemia
13%
Aptamer
13%
Sulfhemoglobinemia
13%
Health System
13%
Host Cell
13%
Biological Therapy
13%
Blood Culture
13%
Ticagrelor
13%
Renal Replacement Therapy
13%
Angiotensin Converting Enzyme 2
13%
End Stage Renal Disease
13%
Hysterectomy
13%
Thrombophilia
13%
Placenta Accreta Spectrum
13%
Gastrointestinal Bleeding
13%